FDA Approves Second Booster For Older Adults, Some Immunocompromised People

On Tuesday, the U.S. Food and Drug Administration (FDA) authorized a second booster shot for adults 50 years of age and up for the Pfizer and Moderna COVID-19 vaccines, and for specific immunocompromised people in certain ways.

The FDA stated: 

A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.

A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise.